From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.

ABSTRACT: Despite all the important advances in its diagnosis and treatment, acute myocardial infarction (AMI) is still one of the most prominent causes of morbidity and mortality worldwide. Early identification of patients at high risk of poor outcomes through the measurement of various biomarker concentrations might contribute to more accurate risk stratification and help to guide more individualized therapeutic strategies, thus improving prognoses. The aim of this article is to provide an overview of the role and applications of cardiac biomarkers in risk stratification and prognostic assessment for patients with myocardial infarction. Although there is no ideal biomarker that can provide prognostic information for risk assessment in patients with AMI, the results obtained in recent years are pro

SUBMITTER: Statescu C 

PROVIDER: S-EPMC9409468 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature